Pearl River Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,376
Closed -$281K 499
2022
Q2
$281K Buy
+6,376
New +$276K 0.07% 362
2021
Q2
Sell
-14,048
Closed -$586K 479
2021
Q1
$586K Buy
+14,048
New +$641K 0.19% 168
2019
Q1
Sell
-405
Closed -$6K 517
2018
Q4
$6K Buy
+405
New +$6.46K 0.03% 679

Other funds holding HALO

Pearl River Capital's HALO Position: Q3 2022 in Review

Pearl River Capital sold out of Halozyme (HALO) in Q3 2022, closing a stake of 6,376 shares — an estimated $281K sold.

Pearl River Capital first reported a position in HALO in Q4 2018 and held it in 3 quarters. The position peaked at $586K in Q1 2021. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

  • Pearl River Capital reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
  • Pearl River Capital sold 6,376 Halozyme shares in Q3 2022, an estimated $281K.
  • Pearl River Capital first reported a position in Halozyme in Q4 2018 and held it in 3 quarters.
  • Pearl River Capital's Halozyme position peaked at $586K in Q1 2021.
  • 357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Pearl River Capital's 13F filing for Q3 2022, filed 14 Nov 2022.